Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Alimentary Pharmacology & Therapeutics
|
December 15, 2021
Editorial: targeting liver biopsy in NAFLD - the need to expand non-invasive tools
Luis Calzadilla Bertot
International Journal of Molecular Sciences
|
May 24, 2016
The Natural Course of Non-Alcoholic Fatty Liver Disease
Luis Calzadilla Bertot, Leon Anton Adams
Alimentary Pharmacology & Therapeutics
|
April 23, 2024
Editorial: Crystalising the burden of steatotic liver disease
Luis Calzadilla Bertot, Leon A Adams
Expert Review of Gastroenterology & Hepatology
|
February 23, 2019
Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease
Luis Calzadilla Bertot, Leon A Adams
Hepatology (Baltimore, Md.)
|
February 13, 2024
Letter to the Editor: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease
Luis Calzadilla-Bertot, Angus W Jeffrey, Gary P Jeffrey
European Radiology
|
August 23, 2011
Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review
Luis Calzadilla Bertot, Masaya Sato, Ryosuke Tateishi, et al.
Hepatology (Baltimore, Md.)
|
December 5, 2020
REPLY
Luis Calzadilla-Bertot, Eduardo Vilar-Gomez, Jacob George, et al.
Hepatology (Baltimore, Md.)
|
June 12, 2016
Reply
Eduardo Vilar-Gomez, Luis Calzadilla-Bertot, Scott L Friedman, et al.
Acta Gastroenterologica Latinoamericana
|
December 6, 2013
[Nonalcoholic fatty liver disease. A current perspective]
Luis Alberto Pérez Blanco, Eduardo Vilar Gómez, Yadina Martínez Pérez, et al.
Hepatology International
|
July 24, 2015
Model for End-Stage Liver Disease and liver cirrhosis-related complications
Luis Calzadilla Bertot, Eduardo Vilar Gomez, Linnet Alonso Almeida, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Alimentary Pharmacology & Therapeutics
|
December 15, 2021
Editorial: targeting liver biopsy in NAFLD - the need to expand non-invasive tools
Luis Calzadilla Bertot
International Journal of Molecular Sciences
|
May 24, 2016
The Natural Course of Non-Alcoholic Fatty Liver Disease
Luis Calzadilla Bertot, Leon Anton Adams
Alimentary Pharmacology & Therapeutics
|
April 23, 2024
Editorial: Crystalising the burden of steatotic liver disease
Luis Calzadilla Bertot, Leon A Adams
Expert Review of Gastroenterology & Hepatology
|
February 23, 2019
Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease
Luis Calzadilla Bertot, Leon A Adams
Hepatology (Baltimore, Md.)
|
February 13, 2024
Letter to the Editor: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease
Luis Calzadilla-Bertot, Angus W Jeffrey, Gary P Jeffrey
European Radiology
|
August 23, 2011
Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review
Luis Calzadilla Bertot, Masaya Sato, Ryosuke Tateishi, et al.
Hepatology (Baltimore, Md.)
|
December 5, 2020
REPLY
Luis Calzadilla-Bertot, Eduardo Vilar-Gomez, Jacob George, et al.
Hepatology (Baltimore, Md.)
|
June 12, 2016
Reply
Eduardo Vilar-Gomez, Luis Calzadilla-Bertot, Scott L Friedman, et al.
Acta Gastroenterologica Latinoamericana
|
December 6, 2013
[Nonalcoholic fatty liver disease. A current perspective]
Luis Alberto Pérez Blanco, Eduardo Vilar Gómez, Yadina Martínez Pérez, et al.
Hepatology International
|
July 24, 2015
Model for End-Stage Liver Disease and liver cirrhosis-related complications
Luis Calzadilla Bertot, Eduardo Vilar Gomez, Linnet Alonso Almeida, et al.
Page
of 5